Showing results (31-40 of 127) with videos related to

Sort By:
Pageof 13
Health Policy (Amsterdam, Netherlands)|September 13, 2005
Implementing WHO DOTS strategy in the Russian Federation: stakeholder attitudesRifat A Atun, Juan Baeza, Francis Drobniewski, et al.
BMC Public Health|October 19, 2010
Increasing reports of non-tuberculous mycobacteria in England, Wales and Northern Ireland, 1995-2006Jonathan E Moore, Michelle E Kruijshaar, L Peter Ormerod, et al.
Plos Medicine|October 5, 2016
Whole Genome Sequence Analysis of a Large Isoniazid-Resistant Tuberculosis Outbreak in London: A Retrospective Observational StudyNicola Casali, Agnieszka Broda, Simon R Harris, et al.
International Journal of STD & AIDS|May 19, 2007
High coverage with HAART is required to substantially reduce the number of deaths from tuberculosis: system dynamics simulationRifat A Atun, Reda M Lebcir, Francis Drobniewski, et al.
Plos One|October 23, 2013
First evaluation after implementation of a quality control system for the second line drug susceptibility testing of Mycobacterium tuberculosis joint efforts in low and high incidence countriesDoris Hillemann, Sven Hoffner, Daniela Cirillo, et al.
BMC Medicine|August 31, 2013
Rapid diagnostics of tuberculosis and drug resistance in the industrialized world: clinical and public health benefits and barriers to implementationFrancis Drobniewski, Vladyslav Nikolayevskyy, Horst Maxeiner, et al.
BMJ (Clinical Research Ed.)|December 13, 2005
Risk factors for pulmonary tuberculosis in Russia: case-control studyRichard Coker, Martin McKee, Rifat Atun, et al.
International Journal of Antimicrobial Agents|December 26, 2016
pncA mutations are associated with slower sputum conversion during standard treatment of multidrug-resistant tuberculosisXubin Zheng, Zhu Ning, Francis Drobniewski, et al.
Thorax|September 9, 2015
A systematic review and meta-analysis of the efficacy and safety of N-acetylcysteine in preventing aminoglycoside-induced ototoxicity: implications for the treatment of multidrug-resistant TBKatharina Kranzer, Wael F Elamin, Helen Cox, et al.
Human Vaccines & Immunotherapeutics|March 11, 2025
Factors influencing vaccine hesitancy among United Kingdom adolescents in a senior high school environment and actions to address itFrancis Drobniewski, Marcia Ashmi, Raheelah Ahmad, et al.
Pageof 13